Evidence map›Paper›PMID 41132387›Full record

ArticleACS sustainable chemistry & engineering2025

Mechanochemical Extrusion for Sustainable Synthesis of Amides and Amines via the Leuckart Reaction.

Francesco Zorzetto, Alvise Perosa, Daily Rodriguez-Padron, Maurizio Selva

Abstract read
In one paragraph

Article in ACS sustainable chemistry & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Francesco ZorzettoDepartment of Molecular Science and Nanosystems, Ca' Foscari University of Venice, Via Torino 155, Mestre, Venezia 30175, Italy.ORCID https://orcid.org/0009-0001-1142-1156
Alvise PerosaDepartment of Molecular Science and Nanosystems, Ca' Foscari University of Venice, Via Torino 155, Mestre, Venezia 30175, Italy.ORCID https://orcid.org/0000-0003-4544-8709
Daily Rodriguez-PadronDepartment of Molecular Science and Nanosystems, Ca' Foscari University of Venice, Via Torino 155, Mestre, Venezia 30175, Italy.ORCID https://orcid.org/0000-0002-8417-7035
Maurizio SelvaDepartment of Molecular Science and Nanosystems, Ca' Foscari University of Venice, Via Torino 155, Mestre, Venezia 30175, Italy.ORCID https://orcid.org/0000-0002-9986-2393

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An extrusion-based, solvent-free method was developed for the synthesis of amides and amines via the Leuckart reaction, representing the first adaptation of this classical transformation into a continuous mechanochemical platform. The production of amides was demonstrated through the model reaction between ammonium formate and vanillin, leading to vanillyl formamide, while the synthesis of tertiary amines was investigated using ammonium formate, vanillin, and morpholine as reactants. A thorough parametric analysis revealed that the mechanochemical-based strategy allowed extremely fast processes: at 100-150 °C, reactions were quantitative in 5-15 min with product selectivity >99% for vanillin formamide and up to 83% for the corresponding tertiary amine. An investigation of the substrate scope (four examples) confirmed the robustness of the protocol for both reaction types. Benzyl-type amides and tertiary amines were synthesized with high conversion and selectivity, exceeding 95%, across different aldehydes. Moreover, morpholine could be successfully replaced by other secondary amines (diethanolamine and

Indexed as

extrusionheterogeneous catalysismechanochemistryreductive aminationsolvent-free

Identifiers

PMID41132387
PMCPMC12541804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.